Über das Unternehmen
- Firmenname (rechtlich): Chengdu Climb Pharmaceutical Technology Co., Ltd.
- Internationaler Name: 成都克莱蒙医药科技有限公司 (Chengdu Climb Pharmaceutical Technology Co., Ltd.), Chengdu, Sichuan, China
- Marke / Handelsname: Climb
- Registrierungsland: China
- Adresse: Room 909-911, Building C1, No. 88 Keyuan South Road, Tianfu Life Science & Technology Park, Gaoxin District, Chengdu 610041, Sichuan, China • Sichuan
- Gründungsjahr: 2013
Beschreibung:
Chengdu Climb Pharmaceutical Technology Co., Ltd., established in 2013, manufactures and trades active pharmaceutical ingredients and pharmaceutical intermediates and fine chemicals for markets worldwide. The company offers contract manufacturing services and is recognized for its international approvals, experienced R&D staff, production capacity and quality service.
Geschäftsaktivitäten
Pharmazeutische Wirkstoffe (API)
LieferantAPI-HerstellerHersteller
Fertigarzneiformen
Hersteller
Vertrags- & Outsourcing-Dienstleistungen
Dienstleister
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Republic of Korea, Japan
- Western Asia: Cyprus
- Northern Europe: Denmark, Finland, Iceland, Ireland, Norway, Sweden, United Kingdom
- Southern Europe: Andorra, Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain, Vatican City
- Western Europe: Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, Netherlands, Switzerland
Hauptprodukte/-dienstleistungen
- Pharmazeutische Wirkstoffe (API): Palbociclib, Etoricoxib, Active Pharmaceutical Ingredients, Brivaracetam, Avibactam Sodium, Apixaban, Vinpocetine, Parecoxib Sodium, Rupatadine fumarate, Macitentan, Moxifloxacin hydrochloride, Anacetrapib, Anamorelin, AZD9291, Cinacalcet HCl, Desvenlafaxine succinate, Macimorelin Acetate, Parecoxib Sodium cas:197502-82-2, Phenylethyl caffeate, ROLAPITANT, Tirofiban hydrochloride monohydrate
- Fertigarzneiformen: Lactulose oral solution, Finished antibiotic medicines
- Pharmazeutische Chemikalien: Active Pharmaceutical Ingredients, Pharmaceutical Intermediates, (R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol, 6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one, (S,S)-2,8-Diazabicyclo[4,3,0]nonane, Vincamine, 1-(6-Methylpyridin-3-yl)-2-[4(methylsulfonyl)phenyl]ethanone, 4-Methylsulfonyl phenyl acetic acid, 1-(6-methylpyridin-3-yl)-2-(4-(methylthio)phenyl)ethanone, 10,10-dimethylanthrone, 2-Chloro-1,3-bis(dimenthylamino)trimethinium hexafluorophosphate, 2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3d] pyrimidine-6-carboxamide, 2'-(Chloromethyl)-4-fluoro-5-isopropyl-2-Methoxy-4'- (trifluoroMethyl)-1,1'-biphenyl, 2-(trifluoromethyl)pyridin -4-amine, 2,4-dichloro-6-(6-(trifluoromethyl)pyridin -2-yl)-1,3,5-triazine, (2S,5R)- 5-(benzyloxyamino)piperidine -2-carboxamide, (2S,5R)-5-[(benzyloxy)amino]piperidine -2-carboxylic acid benzyl ester ethanedioate, (2s,5r)-5-((phenylmethoxy)amino) -2-piperidinecarboxylic acid ethyl ester ethanedioate, (2S,5R)-benzyl 5-(benzyloxyamino)piperidine -2-carboxylate, 3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone, 3-(Chloromethyl)-5-methylpyridine, (3R)-3-(Phenylmethyl)-3-piperidinecarboxylic acid trimethylhydrazide, 4-(4-Chlorobutyl)pyridine hydrochloride, 4-[6-[(6-Bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7- oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridin, 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate, 4'-FLUORO-2'-METHOXY-5'-ISOPROPYL-4-TRIFLUOROMETHYL-1,1'-BIPHENYL-2-METHANOL, 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo- 1H-pyrazolo[3,4-c]pyridine-3-carboxy, (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl] -4-methyl-1,3-oxazolidin- 2-one, 5-(4-Bromophenyl)-4,6-dichloropyrimidine, 5-Bromo-2-chloropyrimidine, 5-hydroxy-4-propyl-2(5H)-furanone, 5-Methyl-3,4-diphenyl- Isoxazole, 6-Benzofurancarboxylic acid, 6-Isoquinolinecarboxylic acid, 5,7-dichloro-1,2,3,4-tetrahydro-, hydrochloride, Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate, Methyl-6-methylnicotinate, methyl 6-(trifluoromethyl)picolinate, N-[2-Chloro-3-bis(dimethylamino)trimethinium, N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine, N-Butylsulfonyl-L-tyrosine, N-Propyl-sulfamide potassium salt, N-Propyl-sulfamide sodium salt, N-Propylsulfamide, N1-[2-(diMethylaMino)ethyl] -5-Methoxy-N1-Methyl-N4-[4-(1- Methyl-1H-indol-3-yl)-2-pyriMidinyl]benze, (R)-1-(1-(bromomethoxy)ethyl) -3,5-bis(trifluoromethy l)benzene, (R)-Dihydro-4-propyl-2(3H)-furanone, Rucaparib, Tabersonine, VALDECOXIB
- ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch): Desloratadine
Unsere Produkte & Dienstleistungen
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
![(2S,5R)-5-[(benzyloxy)amino]piperidine -2-carboxylic acid benzyl ester ethanedioate](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F2s5r-5-benzyloxyaminopiperidine--2-carbo-78005.jpg&w=640&q=75)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
![Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fethyl-chloro4-methoxyphenylhydrazonoacet-78013.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
![N1-[2-(diMethylaMino)ethyl] -5-Methoxy-N1-Methyl-N4-[4-(1- Methyl-1H-indol-3-yl)-2-pyriMidinyl]benze](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fn1-2-dimethylaminoethyl--5-methoxy-n1-me-78016.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen